BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37302266)

  • 21. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycoprotein VI is not a Functional Platelet Receptor for Fibrin Formed in Plasma or Blood.
    Zhang D; Ebrahim M; Adler K; Blanchet X; Jamasbi J; Megens RTA; Uhland K; Ungerer M; Münch G; Deckmyn H; Weber C; Elia N; Lorenz R; Siess W
    Thromb Haemost; 2020 Jun; 120(6):977-993. PubMed ID: 32492725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation.
    Jooss NJ; Smith CW; Slater A; Montague SJ; Di Y; O'Shea C; Thomas MR; Henskens YMC; Heemskerk JWM; Watson SP; Poulter NS
    J Thromb Haemost; 2022 Nov; 20(11):2617-2631. PubMed ID: 35894121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated platelet activation and the potential of previously activated platelets to contribute to thrombus formation.
    De Simone I; Baaten CCFMJ; Gibbins JM; Ten Cate H; Heemskerk JWM; Jones CI; van der Meijden PEJ
    J Thromb Haemost; 2023 May; 21(5):1289-1306. PubMed ID: 36754678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation.
    Mammadova-Bach E; Ollivier V; Loyau S; Schaff M; Dumont B; Favier R; Freyburger G; Latger-Cannard V; Nieswandt B; Gachet C; Mangin PH; Jandrot-Perrus M
    Blood; 2015 Jul; 126(5):683-91. PubMed ID: 25977585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential integrin activity mediated by platelet collagen receptor engagement under flow conditions.
    Pugh N; Maddox BD; Bihan D; Taylor KA; Mahaut-Smith MP; Farndale RW
    Thromb Haemost; 2017 Jul; 117(8):1588-1600. PubMed ID: 28536721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.
    Zheng H; Yu WM; Waclaw RR; Kontaridis MI; Neel BG; Qu CK
    Sci Signal; 2018 Mar; 11(522):. PubMed ID: 29559584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted phosphotyrosine profiling of glycoprotein VI signaling implicates oligophrenin-1 in platelet filopodia formation.
    Bleijerveld OB; van Holten TC; Preisinger C; van der Smagt JJ; Farndale RW; Kleefstra T; Willemsen MH; Urbanus RT; de Groot PG; Heck AJ; Roest M; Scholten A
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1538-43. PubMed ID: 23619296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxepin inhibits GPVI-dependent platelet Ca
    Geue S; Walker-Allgaier B; Eißler D; Tegtmeyer R; Schaub M; Lang F; Gawaz M; Borst O; Münzer P
    Am J Physiol Cell Physiol; 2017 Jun; 312(6):C765-C774. PubMed ID: 28404545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine histiocytic sarcoma cell lines with SHP2 p.Glu76Gln or p.Glu76Ala mutations are sensitive to allosteric SHP2 inhibitor SHP099.
    Tani H; Kurita S; Miyamoto R; Ochiai K; Tamura K; Bonkobara M
    Vet Comp Oncol; 2020 Jun; 18(2):161-168. PubMed ID: 31339650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.
    Vara D; Campanella M; Pula G
    Br J Pharmacol; 2013 Jan; 168(1):212-24. PubMed ID: 22881838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The collagen receptor glycoprotein VI promotes platelet-mediated aggregation of β-amyloid.
    Donner L; Toska LM; Krüger I; Gröniger S; Barroso R; Burleigh A; Mezzano D; Pfeiler S; Kelm M; Gerdes N; Watson SP; Sun Y; Elvers M
    Sci Signal; 2020 Aug; 13(643):. PubMed ID: 32753479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type.
    Jooss NJ; Henskens YMC; Watson SP; Farndale RW; Gawaz MP; Jandrot-Perrus M; Poulter NS; Heemskerk JWM
    Thromb Haemost; 2023 Jun; 123(6):597-612. PubMed ID: 36807826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020).
    Wu J; Zhang H; Zhao G; Wang R
    Curr Med Chem; 2021; 28(19):3825-3842. PubMed ID: 32988341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber.
    Florian P; Wonerow P; Harder S; Kuczka K; Dubar M; Graff J
    Eur J Clin Pharmacol; 2017 Aug; 73(8):949-956. PubMed ID: 28523478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
    Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
    Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-GPVI Fab reveals distinct roles for GPVI signaling in the first platelet layer and subsequent layers during microfluidic clotting on collagen with or without tissue factor.
    Zhang Y; Trigani KT; Shankar KN; Crossen J; Liu Y; Sinno T; Diamond SL
    Thromb Res; 2022 Oct; 218():112-129. PubMed ID: 36037547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation.
    Lisman T; Adelmeijer J; Heijnen HF; de Groot PG
    Blood; 2004 Mar; 103(5):1720-7. PubMed ID: 14592825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.